Allergen Immunotherapy

Allergen immunotherapy gradually desensitizes the immune system to specific allergens through regular controlled exposure, administered as injections or as sublingual drops or tablets, aiming to reduce allergy symptoms and medication dependence over the long term. Unlike medications that only control symptoms, immunotherapy modifies the underlying immune response to the allergen, offering benefits that can persist even after treatment is completed. Treatment begins with a build-up phase of gradually increasing doses, followed by a longer maintenance phase. It is one of the few allergy treatments capable of altering the natural course of the disease rather than simply masking symptoms.

Allergen Immunotherapy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Allergy & Immunology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 3-5 years of regular treatment. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Patients are observed for thirty minutes after each injection dose for reaction monitoring. Symptom improvement is typically noticeable after six to twelve months of treatment, and the course is continued for several years to achieve lasting benefit.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Allergen Immunotherapy has a documented success rate of 70-80% long-term symptom reduction at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.